Pro Share Advisors LLC Supernus Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 14,168 shares of SUPN stock, worth $698,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,168
Previous 14,438 1.87%
Holding current value
$698,057
Previous $472,000 5.51%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$30.29 - $33.43 $8,178 - $9,026
-270 Reduced 1.87%
14,168 $446,000
Q1 2025

May 08, 2025
SELL
$31.17 - $40.0 $106,009 - $136,040
-3,401 Reduced 19.06%
14,438 $472,000
Q4 2024

Feb 13, 2025
BUY
$31.89 - $37.83 $127,815 - $151,622
4,008 Added 28.98%
17,839 $645,000
Q3 2024

Nov 13, 2024
SELL
$25.77 - $35.16 $214,432 - $292,566
-8,321 Reduced 37.56%
13,831 $431,000
Q2 2024

Aug 13, 2024
BUY
$25.99 - $33.85 $215,535 - $280,718
8,293 Added 59.84%
22,152 $592,000
Q1 2024

May 08, 2024
BUY
$27.11 - $35.17 $27,679 - $35,908
1,021 Added 7.95%
13,859 $472,000
Q4 2023

Feb 14, 2024
BUY
$22.72 - $29.68 $37,919 - $49,535
1,669 Added 14.94%
12,838 $371,000
Q3 2023

Nov 13, 2023
SELL
$27.57 - $32.91 $4,686 - $5,594
-170 Reduced 1.5%
11,169 $307,000
Q2 2023

Aug 10, 2023
BUY
$29.91 - $38.73 $8,285 - $10,728
277 Added 2.5%
11,339 $340,000
Q1 2023

May 11, 2023
SELL
$34.93 - $42.03 $47,749 - $57,455
-1,367 Reduced 11.0%
11,062 $400,000
Q4 2022

Feb 02, 2023
BUY
$31.09 - $37.88 $33,204 - $40,455
1,068 Added 9.4%
12,429 $443,000
Q3 2022

Nov 04, 2022
BUY
$28.79 - $35.41 $4,721 - $5,807
164 Added 1.46%
11,361 $384,000
Q2 2022

Aug 01, 2022
SELL
$25.33 - $34.25 $136,022 - $183,922
-5,370 Reduced 32.41%
11,197 $323,000
Q1 2022

May 10, 2022
SELL
$28.51 - $32.9 $93,940 - $108,405
-3,295 Reduced 16.59%
16,567 $536,000
Q4 2021

Feb 08, 2022
BUY
$26.37 - $34.22 $22,229 - $28,847
843 Added 4.43%
19,862 $578,000
Q3 2021

Nov 12, 2021
SELL
$23.54 - $31.39 $110,496 - $147,344
-4,694 Reduced 19.8%
19,019 $507,000
Q2 2021

Aug 13, 2021
BUY
$26.72 - $33.19 $48,683 - $60,472
1,822 Added 8.32%
23,713 $730,000
Q1 2021

May 14, 2021
BUY
$24.15 - $31.45 $46,947 - $61,138
1,944 Added 9.75%
21,891 $573,000
Q4 2020

Feb 09, 2021
BUY
$17.7 - $25.81 $80,163 - $116,893
4,529 Added 29.37%
19,947 $502,000
Q3 2020

Nov 13, 2020
SELL
$20.2 - $25.05 $9,817 - $12,174
-486 Reduced 3.06%
15,418 $321,000
Q2 2020

Aug 03, 2020
BUY
$17.09 - $24.89 $84,458 - $123,006
4,942 Added 45.08%
15,904 $378,000
Q1 2020

May 15, 2020
SELL
$14.45 - $24.69 $122,882 - $209,963
-8,504 Reduced 43.69%
10,962 $197,000
Q4 2019

Feb 12, 2020
SELL
$19.93 - $29.13 $33,382 - $48,792
-1,675 Reduced 7.92%
19,466 $462,000
Q3 2019

Nov 12, 2019
SELL
$25.47 - $33.37 $21,343 - $27,964
-838 Reduced 3.81%
21,141 $581,000
Q2 2019

Aug 13, 2019
SELL
$29.96 - $38.87 $78,015 - $101,217
-2,604 Reduced 10.59%
21,979 $727,000
Q1 2019

May 15, 2019
BUY
$32.77 - $41.99 $8,061 - $10,329
246 Added 1.01%
24,583 $861,000
Q4 2018

Feb 14, 2019
SELL
$30.84 - $49.51 $131,532 - $211,160
-4,265 Reduced 14.91%
24,337 $808,000
Q3 2018

Nov 14, 2018
SELL
$42.7 - $56.55 $54,912 - $72,723
-1,286 Reduced 4.3%
28,602 $1.44 Million
Q2 2018

Aug 13, 2018
SELL
$44.1 - $59.85 $69,898 - $94,862
-1,585 Reduced 5.04%
29,888 $1.79 Million
Q1 2018

May 14, 2018
SELL
$37.15 - $46.9 $180,957 - $228,449
-4,871 Reduced 13.4%
31,473 $1.44 Million
Q4 2017

Feb 14, 2018
BUY
$36.4 - $42.6 $128,928 - $150,889
3,542 Added 10.8%
36,344 $1.45 Million
Q3 2017

Nov 13, 2017
BUY
$36.75 - $49.65 $75,521 - $102,030
2,055 Added 6.68%
32,802 $1.31 Million
Q2 2017

Aug 11, 2017
BUY
N/A
30,747
30,747 $1.33 Million

Others Institutions Holding SUPN

# of Institutions
313
Shares Held
61.5M
Call Options Held
18.4K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.64B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email